SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-012876
Filing Date
2022-05-11
Accepted
2022-05-11 17:13:11
Documents
16
Period of Report
2022-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42755
2 ex10-1.htm EX-10.1 23612
3 ex99-1.htm EX-99.1 7454
4 ex10-1_001.jpg GRAPHIC 2964
5 ex99-1_001.jpg GRAPHIC 14412
  Complete submission text file 0001493152-22-012876.txt   277027

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eltp-20220511.xsd EX-101.SCH 3042
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eltp-20220511_lab.xml EX-101.LAB 34476
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eltp-20220511_pre.xml EX-101.PRE 22601
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3394
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 22914692
SIC: 2834 Pharmaceutical Preparations